When.com Web Search

  1. Ads

    related to: aspirin and dipyridamole for stroke victims information report

Search results

  1. Results From The WOW.Com Content Network
  2. Dipyridamole - Wikipedia

    en.wikipedia.org/wiki/Dipyridamole

    A combination of dipyridamole and aspirin (acetylsalicylic acid/dipyridamole) is FDA-approved for the secondary prevention of stroke and has a bleeding risk equal to that of aspirin use alone. [4] Dipyridamole absorption is pH-dependent and concomitant treatment with gastric acid suppressors (such as a proton pump inhibitor) will inhibit the ...

  3. Acetylsalicylic acid/dipyridamole - Wikipedia

    en.wikipedia.org/.../dipyridamole

    The combination drug acetylsalicylic acid/dipyridamole (trade names Aggrenox, Asasantin) is a drug combination of: [1] Dipyridamole, a drug that inhibits platelet activation [2] when given chronically and causes vasodilation when given at high doses over short time. The combination acts as an extended release formulation and is primarily used ...

  4. Thrombosis prevention - Wikipedia

    en.wikipedia.org/wiki/Thrombosis_prevention

    ICD-9-CM. 437.6, 453, 671.5, 671.9. [ edit on Wikidata] Thrombosis prevention or thromboprophylaxis is medical treatment to prevent the development of thrombosis (blood clots inside blood vessels) in those considered at risk for developing thrombosis. [ 1 ] Some people are at a higher risk for the formation of blood clots than others, such as ...

  5. Antiplatelet drug - Wikipedia

    en.wikipedia.org/wiki/Antiplatelet_drug

    Antiplatelet drug. An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation [1] and inhibit thrombus formation. They are effective in the arterial circulation where classical Vitamin K antagonist ...

  6. Ticagrelor - Wikipedia

    en.wikipedia.org/wiki/Ticagrelor

    In the US, ticagrelor is indicated to reduce the risk of stroke in people with acute ischemic stroke or high-risk transient ischemic attack. [5]In the EU, ticagrelor, co-administered with acetylsalicylic acid (aspirin), is indicated for the prevention of atherothrombotic events in adults with acute coronary syndromes or a history of myocardial infarction and a high risk of developing an ...

  7. Transient ischemic attack - Wikipedia

    en.wikipedia.org/wiki/Transient_ischemic_attack

    A transient ischemic attack (TIA), commonly known as a mini-stroke, is a minor stroke whose noticeable symptoms usually end in less than an hour. A TIA causes the same symptoms associated with a stroke, such as weakness or numbness on one side of the body, sudden dimming or loss of vision, difficulty speaking or understanding language, slurred speech, or confusion.

  8. Stroke - Wikipedia

    en.wikipedia.org/wiki/Stroke

    Dipyridamole can be added to aspirin therapy to provide a small additional benefit, even though headache is a common side effect. [128] Low-dose aspirin is also effective for stroke prevention after having a myocardial infarction. [89]

  9. Adenosine diphosphate receptor inhibitor - Wikipedia

    en.wikipedia.org/wiki/Adenosine_diphosphate...

    Adenosine diphosphate (ADP) receptor inhibitors are a drug class of antiplatelet agents, used in the treatment of acute coronary syndrome (ACS) or in preventive treatment for patients who are in risk of thromboembolism, myocardial infarction or a stroke. These drugs antagonize the P2Y 12 platelet receptors and therefore prevent the binding of ...